Radionuclide Imaging in Congestive Heart Failure. Assessment of Viability, Sarcoidosis, and Amyloidosis

John P. Bois, Panithaya Chareonthaitawee

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Radionuclide imaging provides both established and emerging diagnostic and prognostic tools to assist clinicians in the management of patients with ischemic cardiomyopathy, cardiac sarcoidosis, and cardiac amyloidosis. This review highlights the underlying pathophysiology of each entity and associated diagnostic and clinical challenges, and describes the available radionuclide imaging techniques. Specific protocols, advantages and disadvantages, comparison with other noninvasive imaging modalities, and discussion of the evolving role of hybrid imaging are also included.

Original languageEnglish (US)
Pages (from-to)119-132
Number of pages14
JournalCardiology clinics
Volume34
Issue number1
DOIs
StatePublished - Feb 2016

Keywords

  • Amyloidosis
  • Cardiac imaging
  • Radionuclide
  • Sarcoidosis
  • Viability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Radionuclide Imaging in Congestive Heart Failure. Assessment of Viability, Sarcoidosis, and Amyloidosis'. Together they form a unique fingerprint.

Cite this